1 |
NCT01772823 |
Completed Has Results |
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis |
|
- Behavioral: 3MV
- Behavioral: PCC
- Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
|
Interventional |
Phase 2 |
- University of North Carolina, Chapel Hill
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- National Institute of Mental Health (NIMH)
|
Other / NIH |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Number of Participants With Serum Creatinine Event of Grade 1 or Higher
- Number of Participants With Decrease in Absolute Bone Mineral Density (BMD) From Baseline to Week 48
- Lumbar Spine Bone Mineral Density at Baseline and at Week 48
- (and 50 more...)
|
200 |
Male |
18 Years to 22 Years (Adult) |
NCT01772823 |
ATN 110 Version 3.0 |
|
November 2012 |
November 2015 |
November 2015 |
January 21, 2013 |
January 17, 2018 |
December 21, 2017 |
- Children's Hospital of Los Angeles
Los Angeles, California, United States - University of Colorado - The Children's Hospital of Denver
Aurora, Colorado, United States - University of Miami
Miami, Florida, United States - (and 9 more...)
|
2 |
NCT01751620 |
Completed |
Project ACCEPT: Engaging Newly Diagnosed HIV+ Youth in Care |
- HIV Positive Youth That Are Newly Engaged in Care
|
- Behavioral: Project ACCEPT
- Behavioral: HEALTH
|
Interventional |
Not Applicable |
- University of North Carolina, Chapel Hill
- National Institute on Drug Abuse (NIDA)
- National Institute of Mental Health (NIMH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Examine the efficacy of Project ACCEPT compared with an attention-controlled health education comparison intervention
- Explore the relationship between HIV biomarkers and participant's level of engagement in care
|
167 |
All |
16 Years to 24 Years (Child, Adult) |
NCT01751620 |
ATN 108 |
|
January 2013 |
June 2015 |
June 2015 |
December 18, 2012 |
February 28, 2017 |
|
- University of Miami School of Medicine
Miami, Florida, United States - Stroger Hospital and the CORE Center
Chicago, Illinois, United States - Wayne State University
Detroit, Michigan, United States - St. Jude Childrens Research Hospital
Memphis, Tennessee, United States
|
3 |
NCT01751100 |
Withdrawn |
The Feasibility of Using a General Health Screen to Increase HIV Testing in Community Pharmacies |
|
- Behavioral: HIV Test Offer
- Behavioral: General Health Screen Offer
|
Interventional |
Not Applicable |
- North Bronx Healthcare Network
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Care Provider)
- Primary Purpose: Prevention
|
- Acceptance of HIV Testing
- Proportion of African immigrants that accept HIV testing
- Proportion of IDU that accept HIV testing
- (and 2 more...)
|
0 |
All |
18 Years to 64 Years (Adult) |
NCT01751100 |
RFA-MH-13-092-001 |
|
July 2013 |
May 2016 |
July 2016 |
December 17, 2012 |
May 8, 2015 |
|
- Albert Einstein College of Medicine
Bronx, New York, United States
|
4 |
NCT01768182 |
Completed |
Folinic Acid and Vascular Reactivity in HIV |
- Human Immunodeficiency Virus (HIV) Infection
|
- Dietary Supplement: Folinic Acid
- Other: Placebo
|
Interventional |
Not Applicable |
- Hospital de Clinicas de Porto Alegre
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Prevention
|
- Change in vascular reactivity
- Change in Laboratory measurements
|
30 |
All |
18 Years and older (Adult, Senior) |
NCT01768182 |
08035 |
|
August 2009 |
September 2011 |
September 2011 |
January 15, 2013 |
January 25, 2013 |
|
- Hospital de Clínicas de Porto Alegre
Porto Alegre, RS, Brazil
|
5 |
NCT01756469 |
Completed |
Alcohol Harm Reduction Intervention Among Female Sex Workers in Mombasa, Kenya |
- Alcohol Use and STI/HIV Infections, Domestic Violence
|
- Behavioral: Behavioral Intervention for Alcohol Use
|
Interventional |
Not Applicable |
- FHI 360
- United States Agency for International Development (USAID)
|
Other / U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Investigator)
- Primary Purpose: Prevention
|
- Alcohol use and STI/HIV infection
- Condom use and sexual violence
|
818 |
Female |
18 Years and older (Adult, Senior) |
NCT01756469 |
PHE#KE.09.0235 |
|
March 2011 |
October 2012 |
November 2013 |
December 27, 2012 |
January 9, 2015 |
|
|
6 |
NCT01751646 |
Completed |
Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART |
|
- Dietary Supplement: Vitamin D3 50,000 IU
- Dietary Supplement: Vitamin D3 placebo
|
Interventional |
Not Applicable |
- Westat
- National Institute on Drug Abuse (NIDA)
- National Institute of Mental Health (NIMH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Diagnostic
|
- Compare the percent change from baseline to week 48 in DXA-measured BMD at the spine for the randomized study groups
- Compare change from baseline to week 24 of BMC of whole body and BMD of spine, total hip, and femoral neck for the randomized study groups
- Compare change from baseline to week 48 of BMC of whole body and BMD of spine, total hip, and femoral neck for the randomized study groups
- (and 35 more...)
|
214 |
All |
16 Years to 24 Years (Child, Adult) |
NCT01751646 |
ATN 109 Version 2.0 |
|
October 2012 |
June 2016 |
June 2016 |
December 18, 2012 |
July 4, 2016 |
|
- Children's Hopsital of Los Angeles
Los Angeles, California, United States - University of Southern California - NICHD Westat Site
Los Angeles, California, United States - Childrens National Medical Center
Washington, District of Columbia, United States - (and 16 more...)
|
7 |
NCT01752777 |
Active, not recruiting |
Behavioral Intervention to Enhance HIV Test/Treat |
|
- Behavioral: Infectiousness Risk Reduction
- Behavioral: General Health Improvement
|
Interventional |
Not Applicable |
- University of Connecticut
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Prevention
|
- HIV RNA Viral Load
- Sexual Transmission Risk Behaviors
|
500 |
All |
18 Years to 100 Years (Adult, Senior) |
NCT01752777 |
H11-159 |
|
February 2012 |
February 2018 |
February 2018 |
December 19, 2012 |
May 31, 2017 |
|
- Southeast HIV/AIDS Research and Evaluation Project
Atlanta, Georgia, United States
|
8 |
NCT01764282 |
Completed |
Promoting Antiretroviral Therapy Among Serodiscordant Couples to Reduce HIV Transmission |
|
- Behavioral: comprehensive intervention components
|
Interventional |
Not Applicable |
- National Center for AIDS/STD Control and Prevention, China CDC
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- HIV seroconversion rate of HIV negatives among HIV serodiscordant couples
- Proportion of HIV positives receiving ART among HIV serodiscordant couples
- The incidence rate of AIDS-related diseases of HIV positives among serodiscordant couples
|
11096 |
All |
18 Years to 59 Years (Adult) |
NCT01764282 |
2012ZX10001007-001 |
|
January 1, 2012 |
December 31, 2015 |
December 31, 2015 |
January 9, 2013 |
August 25, 2017 |
|
- Center for Disease Control and Prevention,Guangxi Zhuang Autonomous Region
Nanning, Guilin, Laibin, Qinzhou, Guangxi, China - Center for Disease Control and Prevention, Henan Province
Zhumadian, Henan, China - Center for Disease Control and Prevention, Sichuan Province
Liangshan, Sichuan, China - (and 2 more...)
|
9 |
NCT01751568 |
Recruiting |
Evaluating the Safety, Tolerance, and Pharmacokinetics of a Raltegravir-Containing Antiretroviral Therapy (ART) Regimen in Infants and Children Infected With HIV and TB |
- HIV Infections
- Tuberculosis
|
|
Interventional |
Phase 1 Phase 2 |
- National Institute of Allergy and Infectious Diseases (NIAID)
|
NIH |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Termination from treatment due to adverse events of greater than or equal to Grade 3 deemed at least possibly related to raltegravir
- Death, Grade 4 life-threatening adverse events deemed at least possibly related to raltegravir
- Grade 4 non-life threatening adverse events deemed as probably or definitely related to raltegravir
- (and 4 more...)
|
108 |
All |
up to 11 Years (Child) |
NCT01751568 |
P1101 11831 IMPAACT P1101 |
|
May 2014 |
May 2019 |
|
December 18, 2012 |
May 9, 2017 |
|
- Soweto IMPAACT CRS
Johannesburg, Gauteng, South Africa - Wits RHI Shandukani Research Centre CRS
Johannesburg, Gauteng, South Africa - Desmond Tutu TB Centre - Stellenbosch University (DTTC-SU) CRS
Cape Town, Western Cape Province, South Africa - Fam-Cru Crs
Tygerberg, Western Cape Province, South Africa
|
10 |
NCT01757938 |
Completed |
Randomized Control Trial of Shang Ring Versus Forceps-guided Adult Male Circumcision in Southwestern Uganda. |
|
- Procedure: Shang Ring Guided Circumcision
- Procedure: Forceps Guided Circumcision
|
Interventional |
Not Applicable |
- Mbarara University of Science and Technology
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Procedure Time
- Major Complication
- Pain
- (and 3 more...)
|
138 |
Male |
18 Years and older (Adult, Senior) |
NCT01757938 |
MUST2012-1 |
|
April 2011 |
May 2011 |
May 2011 |
December 31, 2012 |
December 31, 2012 |
|
- Mbarara University of Science and Technology
Mbarara, Uganda
|
11 |
NCT01748968 |
Completed |
Veterans Living With HIV/AIDS: A Pilot Study Examining Risk Factors Associated With Self-Directed Violence |
- Human Immunodeficiency Virus Infection(HIV)/Acquired Immunodeficiency Syndrome (AIDS)
- Self-Directed Violence
|
|
Observational |
|
- VA Eastern Colorado Health Care System
- Public Health Grant Program, Veterans Health Administration Office of Public Health
|
U.S. Fed / Other |
- Observational Model: Cohort
- Time Perspective: Retrospective
|
- Semi-Structured Interview
|
20 |
All |
18 Years to 90 Years (Adult, Senior) |
NCT01748968 |
12-0755 |
|
September 2012 |
September 2015 |
September 2015 |
December 13, 2012 |
December 14, 2015 |
|
- Denver VA
Denver, Colorado, United States
|
12 |
NCT01775436 |
Completed |
Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care |
|
- Behavioral: FAmily-CEntered Advance Care Planning
- Behavioral: Healthy Living Control
|
Interventional |
Not Applicable |
- Children's Research Institute
- Georgetown University
- George Washington University
- (and 2 more...)
|
Other / U.S. Fed |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Supportive Care
|
- Statement of Treatment Preferences
- Lyon Advance Care Planning Survey (Patient and Surrogate Version)
- Palliative Care Outcome Scale (POS)
- Medical Outcomes Study-HIV (MOS-HIV)
|
444 |
All |
18 Years and older (Adult, Senior) |
NCT01775436 |
1R01NR01405201 |
FACE |
October 13, 2013 |
March 28, 2017 |
March 28, 2017 |
January 25, 2013 |
August 31, 2017 |
|
- Georgetown University Hospital
Washington, D.C., District of Columbia, United States - Children's National Medical Center
Washington, D.C., District of Columbia, United States - Institute for Clinical Research, Inc. (Affiliated with Department of Veterans Affairs Medical Center of Washington, DC)
Washington, D.C., District of Columbia, United States - (and 2 more...)
|
13 |
NCT01818856 |
Completed |
Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir |
- Hepatitis C, Chronic
- HIV Infection
|
- Drug: Ritonavir withdrawal, atazanavir 200 mg/12h
- Drug: Telaprevir interactions
|
Interventional |
Phase 1 |
- Hospitales Universitarios Virgen del Rocío
- Bristol-Myers Squibb
|
Other / Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Changes in pharmacokinetic parameters of TVR
- Changes in pharmacokinetic parameters of ATV
|
14 |
All |
18 Years to 65 Years (Adult) |
NCT01818856 |
LLC-TEL-2012-1 2012-002515-25 |
|
December 2012 |
April 2013 |
April 2013 |
March 27, 2013 |
April 22, 2013 |
|
- Hospital Universitario Virgen del Rocio
Seville, Spain
|
14 |
NCT01749007 |
Completed |
Assessment of Cognitive Functioning as it Relates to Risk for Suicide in Veterans With HIV/AIDS |
|
|
Observational |
|
- VA Eastern Colorado Health Care System
|
U.S. Fed |
- Observational Model: Cohort
- Time Perspective: Other
|
- Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV)
- Trail Making Test (TMT): Parts A & B
- California Verbal Learning Test, Second Edition (CVLT-II)
- (and 16 more...)
|
50 |
All |
18 Years to 65 Years (Adult) |
NCT01749007 |
12-1039 |
|
November 2012 |
August 2016 |
January 2017 |
December 13, 2012 |
May 15, 2017 |
|
- Eastern Colorado Health Care System
Denver, Colorado, United States
|
15 |
NCT01754116 |
Completed |
A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects |
- Infection, Human Immunodeficiency Virus
|
- Drug: GSK1265744 30 mg oral
- Drug: Midazolam 3 mg oral + GSK1265744 30mg oral
- Drug: GSK1265744 400 mg (200 nm)
- (and 2 more...)
|
Interventional |
Phase 1 |
- ViiV Healthcare
- GlaxoSmithKline
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Plasma GSK1265744 area under the concentration-time curve for 12 weeks (AUC 0-wk12)
- Plasma GSK1265744 last observed quantifiable concentration at week 12 (Cwk12)
- Plasma GSK1265744 maximum observed concentration (Cmax)
- (and 22 more...)
|
43 |
All |
18 Years to 65 Years (Adult) |
NCT01754116 |
116815 |
|
January 2013 |
April 2014 |
April 2014 |
December 21, 2012 |
April 21, 2014 |
|
- GSK Investigational Site
Overland Park, Kansas, United States
|
16 |
NCT01874743 |
Unknown † |
Rosuvastatin to Decrease Residual Immune Activation in HIV Infection |
|
- Drug: Rosuvastatin 20 mg/day
|
Interventional |
Phase 2 |
- Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
- Sidaction
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
|
- CD8 T cell activation
- Coexpress activation markers
- Rosuvastatin administration (on and off)on biomarkers activation
- (and 4 more...)
|
40 |
All |
18 Years and older (Adult, Senior) |
NCT01874743 |
IMEA 043 CESAR |
CESAR |
March 2012 |
September 2013 |
September 2013 |
June 11, 2013 |
June 12, 2013 |
|
- St Antoine Hospital
Paris, France - HEGP
Paris, France
|
17 |
NCT01813357 |
Unknown † |
Does Rosuvastatin Delay Progression of Atherosclerosis in HIV |
- HIV
- Cardiovascular Disease
|
- Drug: Rosuvastatin
- Other: Placebo
|
Interventional |
Phase 4 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Prevention
|
- Progression of carotid intima media thickness
- Rates of adverse events
|
102 |
All |
18 Years and older (Adult, Senior) |
NCT01813357 |
AH-491/12 ACTRN12612001082897 |
|
March 2013 |
January 2015 |
January 2017 |
March 19, 2013 |
July 15, 2014 |
|
- Alfred Hospital
Melbourne, Victoria, Australia - Hospitaux Universitaires de Geneve
Geneve, Switzerland
|
18 |
NCT01760057 |
Completed |
Evaluating the Effect of a Novel Web-based Intervention to Increase HIV Testing in Men Who Have Sex With Men |
|
- Behavioral: Online HIV testing motivational videos and messages sent via mobile-phone text messaging, e-mail or instant messaging
- Behavioral: Standard online message with an invitation for free HIV testing similar in content to other Peruvian websites
|
Interventional |
Not Applicable |
- Universidad Peruana Cayetano Heredia
- National Institutes of Health (NIH)
- NGO Via Libre
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Screening
|
|
400 |
Male |
18 Years and older (Adult, Senior) |
NCT01760057 |
R01TW008398 |
TuNexo |
January 2013 |
February 2014 |
March 2015 |
January 3, 2013 |
May 28, 2015 |
|
- Universidad Peruana Cayetano Heredia
Lima, Peru
|
19 |
NCT01755754 |
Completed |
A Trial to Assess the Functionality of Female Condom With a Silicone Elastomer Vaginal Ring |
- Human Immunodeficiency Virus
|
- Combination Product: Silicone Elastomer Vaginal Ring
- Device: Female Condom
|
Interventional |
Phase 1 |
- International Partnership for Microbicides, Inc.
|
Industry |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Total clinical failure rate
|
160 |
All |
18 Years to 45 Years (Adult) |
NCT01755754 |
IPM 033 |
|
August 2013 |
March 2014 |
March 2014 |
December 24, 2012 |
September 28, 2017 |
|
- California Family Health Council
Los Angeles, California, United States
|
20 |
NCT01766076 |
Completed Has Results |
Atorvastatin for HAART Suboptimal Responders |
- Acquired Immune Deficiency Syndrome Virus
|
- Other: atorvastatin, Lipitor®
- Drug: Placebo
|
Interventional |
Phase 3 |
- Makerere University
- Vaccine and Gene Therapy Institute, Florida
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Double (Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Percentage Change in Immune Activation Levels After 12 Weeks of Atorvastatin 80mg Daily
|
30 |
All |
18 Years to 90 Years (Adult, Senior) |
NCT01766076 |
HS1258 |
|
January 2013 |
February 2014 |
March 2014 |
January 11, 2013 |
May 21, 2015 |
May 21, 2015 |
|
21 |
NCT01762995 |
Completed |
A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects |
- Infection, Human Immunodeficiency Virus
|
- Drug: Dolutegravir 50 mg
- Drug: Calcium Carbonate 1200 mg
- Drug: Ferrous Fumarate 324 mg
|
Interventional |
Phase 1 |
- ViiV Healthcare
- GlaxoSmithKline
|
Industry |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Single dose plasma DTG PK assessed by AUC (0-t) and AUC (0-infinity)
- Single dose plasma DTG PK assessed by Cmax and C24
- Safety and tolerability assessed by change from baseline in electrocardiogram (ECG)
- (and 7 more...)
|
24 |
All |
18 Years to 65 Years (Adult) |
NCT01762995 |
116898 |
|
December 2012 |
March 2013 |
March 2013 |
January 8, 2013 |
April 22, 2013 |
|
|
22 |
NCT01771237 |
Completed |
HIV Prevention Among Vulnerable Male Youth |
- Homosexuality, Male
- HIV
- Substance-related Disorders
- Sexual Dysfunctions, Psychological
|
- Behavioral: MyPeeps Manualized Group Intervention
- Behavioral: Standard Sexual Health Education
|
Interventional |
Not Applicable |
- Ann & Robert H Lurie Children's Hospital of Chicago
- Howard Brown Health Center
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Change in AIDS-risk behavior (AIDS-Risk Behavior Assessment - ARBA)
|
121 |
Male |
16 Years to 20 Years (Child, Adult) |
NCT01771237 |
R34MH079707 |
|
July 2007 |
January 2011 |
January 2011 |
January 18, 2013 |
February 1, 2018 |
|
- Ann and Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois, United States
|
23 |
NCT01748136 |
Completed |
Screening for Lung Cancer in the HIV Patient |
- Lung Cancer in the HIV Patient
|
- Device: CT Scan with Spirometry
|
Interventional |
Not Applicable |
- Sidney Kimmel Comprehensive Cancer Center
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Stage distribution of HIV-seropositive patients
- To create a specimen bank of serum, sputum, and tissue
|
200 |
All |
26 Years to 100 Years (Adult, Senior) |
NCT01748136 |
J0491 NA_00036809 |
NA_00036809 |
January 2006 |
September 2011 |
September 2011 |
December 12, 2012 |
October 13, 2016 |
|
|
24 |
NCT01751555 |
Completed |
Efficacy and Safety of TDF+3TC+EFV in Adults With HIV/HBV Coinfection |
|
- Drug: Regimen:TDF+3TC+EFV
|
Interventional |
Phase 4 |
- National Center for AIDS/STD Control and Prevention, China CDC
- Gilead Sciences
|
Other / Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Proportion of patients with HIV RNA below LDL and HBV DNA below 2.3log10 copies/ml at week 48
- Incidence of targeted adverse events over 48 weeks
|
100 |
All |
18 Years to 60 Years (Adult) |
NCT01751555 |
co-us-104-0405 |
|
February 2011 |
June 2013 |
June 2013 |
December 18, 2012 |
June 28, 2013 |
|
- National Center for AIDS/STD Control and Prevention, China CDC
Beijing, Beijing, China
|
25 |
NCT01751594 |
Completed |
Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men |
|
- Behavioral: MOVE Intervention
- Behavioral: H4L Comparison Intervention
|
Interventional |
Not Applicable |
- University of North Carolina, Chapel Hill
- National Institute on Drug Abuse (NIDA)
- National Institute of Mental Health (NIMH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Finalize and manualize a critical consciousness based intervention for HIV positive B-YMSM
|
92 |
Male |
16 Years to 24 Years (Child, Adult) |
NCT01751594 |
ATN 104 |
|
April 2012 |
June 2014 |
June 2014 |
December 18, 2012 |
August 1, 2017 |
|
- Children's Hospital of Los Angeles
Los Angeles, California, United States - Stroger Hospital and the CORE Center
Chicago, Illinois, United States - Montefiore Medical Center
The Bronx, New York, United States - (and 2 more...)
|
26 |
NCT01761643 |
Active, not recruiting |
CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM |
- Patient Adherence
- HIV Seronegativity
|
|
Interventional |
Phase 4 |
- California Collaborative Treatment Group
- University of California, San Diego
- University of California, Los Angeles
- (and 4 more...)
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Adherence to PrEP
- Factors associated with poor adherence
- Rate of HIV seroconversion
- (and 3 more...)
|
398 |
Male |
18 Years and older (Adult, Senior) |
NCT01761643 |
CCTG 595 |
|
January 2013 |
April 2016 |
June 2017 |
January 7, 2013 |
February 28, 2017 |
|
- City of Long Beach Department of Health and Human Services
Long Beach, California, United States - University Southern California
Los Angeles, California, United States - University of California, San Diego
San Diego, California, United States - Harbor-UCLA Medical Center
Torrance, California, United States
|
27 |
NCT01764685 |
Terminated Has Results |
Topiramate to Reduce Heavy Drinking in HIV-Positive Heavy Drinkers |
- Heavy Drinking
- HIV
- Alcohol Dependence
|
- Drug: Topiramate
- Behavioral: Medical Management
- Drug: Placebo
|
Interventional |
Phase 2 |
- University of Pennsylvania
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Number of Heavy Drinking Days Per Week by Medication Group
|
4 |
All |
18 Years to 70 Years (Adult, Senior) |
NCT01764685 |
816082 |
|
January 2013 |
January 2014 |
January 2014 |
January 9, 2013 |
March 15, 2016 |
February 17, 2016 |
- University of Pennsylvania Treatment Research Center
Philadelphia, Pennsylvania, United States
|
28 |
NCT01746758 |
Unknown † |
Mobile Phone Text Messaging Referral |
- HIV
- Sexually Transmitted Infections
- Contraception
- Pregnancy
|
- Behavioral: SMS text messaging referral
|
Interventional |
Not Applicable |
- Liverpool School of Tropical Medicine
- National Institute for Medical Research, Tanzania
- Ministry of Health and Social Welfare, Tanzania
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- Increase the number of patients receiving reproductive health services at dispensary and health centre level after referral from a drug store.
- Referred number of patients attending HIV, STI, pregnancy prevention (including numbers of condoms, VCT, and post-abortion care) and treatment
- Referred number of patients attending other contraceptives (the pill, intra-uterine devices, injection, female condom and sterilisation where available)
- (and 3 more...)
|
700 |
All |
15 Years to 19 Years (Child, Adult) |
NCT01746758 |
11.94RS |
SMS4Health |
August 2012 |
January 2014 |
January 2014 |
December 11, 2012 |
December 11, 2012 |
|
- National Institute for Medical Research Tanzania
Mwanza, Tanzania
|
29 |
NCT01761110 |
Completed |
Pilot Test of a Community-based Buprenorphine Treatment Intervention |
- Opioid Dependence
- Injection Drug Use
|
- Behavioral: Community-based buprenorphine treatment (CBBT) intervention
|
Interventional |
Not Applicable |
- Albert Einstein College of Medicine, Inc.
- National Institute on Drug Abuse (NIDA)
- The City University of New York
- Washington Heights Corner Project
|
Other / NIH |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- initiation of buprenorphine treatment
- opioid use
|
77 |
All |
18 Years and older (Adult, Senior) |
NCT01761110 |
2012-381 R34DA031066 |
|
December 2012 |
February 2014 |
February 2014 |
January 4, 2013 |
April 23, 2018 |
|
- Washington Heights Corner Project
New York, New York, United States
|